PRECIGEN, INC. Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share
PRECIGEN, INC. (PGEN) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $0.00 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-19.
Financial Statements › Income Statement › Net Income
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2025-03-19
- PRECIGEN, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2022-09-30 was $0.48.
- PRECIGEN, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2024 was $0.00.
- PRECIGEN, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- PRECIGEN, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2022 was $0.54, a 500.00% increase from fiscal 2021.
- PRECIGEN, INC. income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2021 was $0.09.
| Period end | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 month as first filed | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-19 | |||||||
| 2023-12-31 | $0.00 10-K · filed 2025-03-19 | |||||||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||||||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | ||||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | |||||||
| 2022-12-31 | $0.54 10-K · filed 2025-03-19 | |||||||
| 2022-09-30 | $0.48 10-Q · filed 2023-11-09 | $0.54 10-Q · filed 2023-11-09 | ||||||
| 2022-06-30 | $0.04 10-Q · filed 2023-08-09 | $0.07 10-Q · filed 2023-08-09 | ||||||
| 2022-03-31 | $0.02 10-Q · filed 2023-05-10 | $0.00 10-Q · filed 2022-05-09 | ||||||
| 2021-12-31 | $0.09 10-K · filed 2024-03-19 | $0.02 10-K · filed 2022-03-01 | ||||||
| 2021-09-30 | -$0.02 10-Q · filed 2022-11-09 | $0.00 10-Q · filed 2021-11-08 | $0.09 10-Q · filed 2022-11-09 | $0.02 10-Q · filed 2021-11-08 | ||||
| 2021-06-30 | $0.06 10-Q · filed 2022-08-08 | $0.00 10-Q · filed 2021-08-09 | $0.10 10-Q · filed 2022-08-08 | $0.02 10-Q · filed 2021-08-09 | ||||
| 2021-03-31 | $0.02 10-Q · filed 2022-05-09 | |||||||
| 2020-12-31 | -$0.39 10-K · filed 2023-03-06 | -$0.40 10-K · filed 2022-03-01 | ||||||
| 2020-09-30 | -$0.01 10-Q · filed 2021-11-08 | -$0.40 10-Q · filed 2021-11-08 | ||||||
| 2020-06-30 | -$0.16 10-Q · filed 2021-08-09 | -$0.38 10-Q · filed 2021-08-09 | ||||||
| 2020-03-31 | -$0.22 10-Q · filed 2021-05-10 | |||||||
| 2019-12-31 | -$1.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |